SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Madrigal Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (108)10/7/2019 9:41:46 AM
From: tuck  Respond to of 138
 
A competitor stumbles: NGM's 24 week data show beneficial effect on LFC weakening noticeably from week 12. That stock is firesaling some 30%. There may be other red flags in the data I'm not seeing. Akero, now public (AKRO), and which targets a related pathway, is seeing some collateral damage, off 5% and trading near post IPO lows. MDGL steady so far this morning on a day of some market redness.

Cheers, Tuck